This conversation forms part of a Davos Accredited Programme
From Risk to Return on Investment: Financing the Future of Health in a Changing Climate
Wed 21 Jan 2026 5:00 pm - 7:00 pm (CET/GMT+1)
Flourishing House (Rätia Center: Forum 1)
Climate change is rapidly reshaping health and economic systems, as extreme heat, shifting disease patterns, and growing resource constraints place unprecedented pressure on societies. This session convened by Bayer brings together leaders in business and finance to explore how future-ready research and development, sustainable medicines, and climate-health literacy can catalyse adaptive health systems while unlocking new investment opportunities in productivity, resilience, and well-being. Framed as a strategic investment frontier, the session highlights emerging leadership across East and West — and examines how blended finance and cross-sector partnerships, combining philanthropy, private capital, and public funding, can mobilise resources at scale and catalyse commitments to fund resilient, climate-adaptive health systems.
Panel 1: Resilient by Design: Harnessing Innovation for Climate Smart Solutions
If your products aren’t built for a climate‑altered world, you’re not innovating — you’re gambling
Panel 2: Sustainability in Practice: Reducing Emissions Without Compromising Care
What if the biggest disruption in healthcare isn’t technological at all, but the courage to redesign a system that puts people, not products, at the centre.
Panel 3: Educating for Resilience: Building Climate‑Ready Communities and Health Workforces in an Age of AI
A climate‑ready community or workforce isn’t a sustainability initiative; it’s a survival requirement in a world that’s already changed.
Please note: As space is limited, registrations are subject to confirmation. We warmly encourage early registration, and we’ll do our best to accommodate everyone.
Register to Join
